Liu L - Search Results

1

Plastin 1 drives metastasis of colorectal cancer through the IQGAP1/Rac1/ERK pathway.

Zhang T, Wang Z, Liu Y, Huo Y, Liu H, Xu C, Mao R, Zhu Y, Liu L, Wei D, Liu G, Pan B, Tang Y, Zhou Z, Yang C, Guo Y. Zhang T, et al. Among authors: liu y, liu h, liu l, liu g. Cancer Sci. 2020 Aug;111(8):2861-2871. doi: 10.1111/cas.14438. Epub 2020 Jul 5. Cancer Sci. 2020. PMID: 32350953 Free PMC article.

2

LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription.

Xiu B, Chi Y, Liu L, Chi W, Zhang Q, Chen J, Guo R, Si J, Li L, Xue J, Shao ZM, Wu ZH, Huang S, Wu J. Xiu B, et al. Among authors: liu l. Mol Cancer. 2019 Dec 19;18(1):187. doi: 10.1186/s12943-019-1115-y. Mol Cancer. 2019. PMID: 31856843 Free PMC article.

3

Promotion of esophageal adenocarcinoma metastasis via Wnt/ß-catenin signal pathway by sorting nexins 3.

Pan B, Liu L, Hu X, Sun X, Zhu Y, Zhang T, Wei D, Guo Y, Shan J. Pan B, et al. Among authors: liu l. J Gastroenterol Hepatol. 2020 Dec;35(12):2131-2139. doi: 10.1111/jgh.15039. Epub 2020 May 4. J Gastroenterol Hepatol. 2020. PMID: 32187731

4

NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK-NRF2 signaling.

Yang Y, Zheng J, Wang M, Zhang J, Tian T, Wang Z, Yuan S, Liu L, Zhu P, Gu F, Fu S, Shan Y, Pan Z, Zhou W. Yang Y, et al. Among authors: liu l. Cancer Sci. 2021 Feb;112(2):641-654. doi: 10.1111/cas.14744. Epub 2020 Dec 13. Cancer Sci. 2021. Retraction in: Cancer Sci. 2023 Jul;114(7):3057. doi: 10.1111/cas.15809 PMID: 33222332 Free PMC article. Retracted.

5

A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer.

Liu L, Pang H, He Q, Pan B, Sun X, Shan J, Wu L, Wu K, Yao X, Guo Y. Liu L, et al. Cancer Cell Int. 2021 Jul 2;21(1):335. doi: 10.1186/s12935-021-02007-6. Cancer Cell Int. 2021. PMID: 34215253 Free PMC article.

6

CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer.

Jiang T, Wang H, Liu L, Song H, Zhang Y, Wang J, Liu L, Xu T, Fan R, Xu Y, Wang S, Shi L, Zheng L, Wang R, Song J. Jiang T, et al. Among authors: liu l. Mol Cancer. 2021 Dec 18;20(1):167. doi: 10.1186/s12943-021-01474-9. Mol Cancer. 2021. PMID: 34922544 Free PMC article.

7

FJX1 as a candidate diagnostic and prognostic serum biomarker for colorectal cancer.

Liu L, Huang Y, Li Y, Wang Q, Hao Y, Liu L, Yao X, Yao X, Wei Y, Sun X, Guo Y. Liu L, et al. Clin Transl Oncol. 2022 Oct;24(10):1964-1974. doi: 10.1007/s12094-022-02852-5. Epub 2022 Jun 1. Clin Transl Oncol. 2022. PMID: 35650386

8

IL-33 Participates in the Development of Esophageal Adenocarcinoma.

Liu J, Liu L, Su Y, Wang Y, Zhu Y, Sun X, Guo Y, Shan J. Liu J, et al. Among authors: liu l. Pathol Oncol Res. 2022 Aug 30;28:1610474. doi: 10.3389/pore.2022.1610474. eCollection 2022. Pathol Oncol Res. 2022. PMID: 36110250 Free PMC article.

9

Isoprenaline/β2-AR activates Plexin-A1/VEGFR2 signals via VEGF secretion in gastric cancer cells to promote tumor angiogenesis.

Lu Y, Xu Q, Zuo Y, Liu L, Liu S, Chen L, Wang K, Lei Y, Zhao X, Li Y. Lu Y, et al. Among authors: liu l, liu s. BMC Cancer. 2017 Dec 20;17(1):875. doi: 10.1186/s12885-017-3894-0. BMC Cancer. 2017. PMID: 29262812 Free PMC article.

10

EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis.

Gu F, Yuan S, Liu L, Zhu P, Yang Y, Pan Z, Zhou W. Gu F, et al. Among authors: liu l. J Cell Mol Med. 2019 Jun;23(6):4208-4216. doi: 10.1111/jcmm.14309. Epub 2019 Apr 7. J Cell Mol Med. 2019. PMID: 30957411 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74,162 results

Search Page

Filters